LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs
Amount Raised
$83 Million
Round Type
Series C
UtrechtBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
LAVA Therapeutics, a biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, today announced the closing of an oversubscribed $83 million (€71 million) Series C financing to fund the advancement of its pipeline and platform. The financing was co-led by new investors Novo Ventures, the venture arm of Novo Holdings, and Sanofi Ventures, and included additional new investors Redmile Group, LLC, Ysios Capital and BB Pureos Bioventures. In addition, current investors Versant, Gilde Healthcare and MRL Ventures Fund, LLC participated significantly in the round.
Quick answer
LAVA Therapeutics raised $83 Million in a Series C round, dated September 17, 2020. LAVA Therapeutics is based in Utrecht, Utrecht, Netherlands.
- How much did LAVA Therapeutics raise?
- LAVA Therapeutics raised $83 Million in a Series C round on September 17, 2020.
- What does LAVA Therapeutics do?
- LAVA Therapeutics N.V. is a biopharmaceutical company developing bispecific gamma delta T cell engagers using its Gammabody® platform.
- Where is LAVA Therapeutics based and how big is it?
- LAVA Therapeutics is based in Utrecht, Utrecht, Netherlands. Fundz records about 21 employees.
- Who are the decision-makers at LAVA Therapeutics?
- Fundz holds 1 contact at LAVA Therapeutics, including the Research Associate. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as LAVA Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
- AbSci Corp raised $65M on October 30, 2020.
- Nuvation Bio raised $275M on October 20, 2020.
- HCW Biologics raised $6.2M on October 19, 2020.
- Olema Pharmaceuticals, Inc. raised $87M on October 13, 2020.
- OnKure Therapeutics raised $1.5M (Seed) on September 30, 2020.
Who to call at LAVA Therapeutics, and when
A new round usually means LAVA Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LAVA Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LAVA Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LAVA Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LAVA Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LAVA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.